Isopeptidases in anticancer therapy: looking for inhibitors.

No abstract is available for this paper.

• Publication year

  2010

• Venue

  American journal of translational research

• Publication date

  2010-05-10

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  PMID 20589164PMCID PMC2892408
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Emerging roles of deubiquitinases in cancer‐associated pathways

  2010cited by this paper
• Identification of a novel chemical potentiator and inhibitors of UCH-L1 by in silico drug screening.

  2010cited by this paper
• Synthesis and Biological Evaluation of 9‐Oxo‐9H‐indeno[1,2‐b]pyrazine‐2,3‐dicarbonitrile Analogues as Potential Inhibitors of Deubiquitinating Enzymes

  2010influential reference
• Sensitivity to Poly(ADP-ribose) Polymerase (PARP) Inhibition Identifies Ubiquitin-specific Peptidase 11 (USP11) as a Regulator of DNA Double-strand Break Repair*

  2010cited by this paper
• Identification of USP18 as an important regulator of the susceptibility to IFN-alpha and drug-induced apoptosis.

  2010cited by this paper
• Deubiquitinase USP9X stabilizes MCL1 and promotes tumour cell survival

  2010cited by this paper
• The multiple levels of regulation by p53 ubiquitination

  2010cited by this paper
• USP10 regulates p53 localization and stability by deubiquitinating p53.

  2010cited by this paper
• Inhibition of NF-κB Signaling by A20 Through Disruption of Ubiquitin Enzyme Complexes

  2010cited by this paper
• The therapeutic potential of deubiquitinating enzyme inhibitors.

  2010influential reference
• The BCL-2 family reunion.

  2010cited by this paper
• Origin and function of ubiquitin-like proteins

  2009cited by this paper
• Regulation and cellular roles of ubiquitin-specific deubiquitinating enzymes.

  2009cited by this paper
• Thiopurine Analogue Inhibitors of Severe Acute Respiratory Syndrome-Coronavirus Papain-Like Protease, a Deubiquitinating and deISGylating Enzyme

  2009influential reference
• DUBs and cancer: The role of deubiquitinating enzymes as oncogenes, non-oncogenes and tumor suppressors

  2009cited by this paper
• RNA interference screen identifies Usp18 as a regulator of epidermal growth factor receptor synthesis.

  2009cited by this paper
• USP17 Regulates Ras Activation and Cell Proliferation by Blocking RCE1 Activity*

  2009cited by this paper
• The Isopeptidase Inhibitor G5 Triggers a Caspase-independent Necrotic Death in Cells Resistant to Apoptosis

  2009cited by this paper
• Ubiquitin C-terminal hydrolase-L1 is a key regulator of tumor cell invasion and metastasis

  2009cited by this paper
• Suppression of the Deubiquitinating Enzyme USP5 Causes the Accumulation of Unanchored Polyubiquitin and the Activation of p53*

  2009cited by this paper
• Caspases and kinases in a death grip.

  2009cited by this paper
• Ubiquitin-specific Peptidase 21 Inhibits Tumor Necrosis Factor α-induced Nuclear Factor κB Activation via Binding to and Deubiquitinating Receptor-interacting Protein 1*

  2009cited by this paper
• A time-resolved fluorescence resonance energy transfer-based assay for DEN1 peptidase activity.

  2009cited by this paper
• The CULt of caspase-8 ubiquitination.

  2009cited by this paper
• Breaking the chains: structure and function of the deubiquitinases

  2009influential reference
• Ubiquitin-like sequence in ASK1 plays critical roles in the recognition and stabilization by USP9X and oxidative stress-induced cell death.

  2009cited by this paper
• Nonproteolytic functions of ubiquitin in cell signaling.

  2009cited by this paper
• Cullin3-based polyubiquitination and p62-dependent aggregation of caspase-8 mediate extrinsic apoptosis signaling.

  2009cited by this paper
• FAM/USP9x, a deubiquitinating enzyme essential for TGFbeta signaling, controls Smad4 monoubiquitination.

  2009cited by this paper
• Small-molecule inhibitor of USP7/HAUSP ubiquitin protease stabilizes and activates p53 in cells

  2009cited by this paper
• Induction of the lysosomal apoptosis pathway by inhibitors of the ubiquitin‐proteasome system

  2009influential reference
• Characterization of caspase-dependent and caspase-independent deaths in glioblastoma cells treated with inhibitors of the ubiquitin-proteasome system

  2009cited by this paper
• Recognition and processing of ubiquitin-protein conjugates by the proteasome.

  2009cited by this paper
• The deubiquitinases USP33 and USP20 coordinate β2 adrenergic receptor recycling and resensitization

  2009cited by this paper
• No Splicing, No Dicing: Non-proteolytic Roles of the Ubiquitin-Proteasome System in Transcription*

  2009cited by this paper
• The ubiquitin specific protease 4 (USP4) is a new player in the Wnt signalling pathway

  2009cited by this paper
• The ubiquitin C‐terminal hydrolase UCH‐L1 regulates B‐cell proliferation and integrin activation

  2009cited by this paper
• A noncovalent class of papain-like protease/deubiquitinase inhibitors blocks SARS virus replication

  2008cited by this paper
• Targeting the UPS as therapy in multiple myeloma

  2008cited by this paper
• Atypical ubiquitin chains: new molecular signals

  2008cited by this paper
• The deubiquitinylation and localization of PTEN are regulated by a HAUSP–PML network

  2008cited by this paper
• Recognition of Polyubiquitin Isoforms by the Multiple Ubiquitin Binding Modules of Isopeptidase T*

  2008cited by this paper
• Protein partners of deubiquitinating enzymes.

  2008cited by this paper
• Inhibitors of the Ubiquitin-Proteasome System and the cell death machinery: How many pathways are activated?

  2008cited by this paper
• USP22, an hSAGA subunit and potential cancer stem cell marker, reverses the polycomb-catalyzed ubiquitylation of histone H2A

  2008cited by this paper
• Deubiquitylation of histone H2A activates transcriptional initiation via trans-histone cross-talk with H3K4 di- and trimethylation.

  2008cited by this paper
• Characterization of ubiquitin and ubiquitin-like-protein isopeptidase activities

  2008cited by this paper
• Usp39 is essential for mitotic spindle checkpoint integrity and controls mRNA-levels of Aurora B

  2008cited by this paper
• Interferon-inducible antiviral effectors

  2008cited by this paper
• Targeting ubiquitin specific proteases for drug discovery.

  2008cited by this paper
• Anaphase initiation is regulated by antagonistic ubiquitination and deubiquitination activities

  2007cited by this paper
• The ubiquitin-specific protease USP28 is required for MYC stability

  2007cited by this paper
• Proteolytic Processing and Deubiquitinating Activity of Papain-Like Proteases of Human Coronavirus NL63

  2007cited by this paper
• Human USP3 is a chromatin modifier required for S phase progression and genome stability.

  2007cited by this paper
• Cell death by necrosis: towards a molecular definition.

  2007cited by this paper
• The deubiquitinating enzyme USP2a regulates the p53 pathway by targeting Mdm2

  2007cited by this paper
• Essential Role of Ubiquitin-Specific Protease 8 for Receptor Tyrosine Kinase Stability and Endocytic Trafficking In Vivo

  2007cited by this paper
• Lipid rafts and nonrafts mediate tumor necrosis factor related apoptosis-inducing ligand induced apoptotic and nonapoptotic signals in non small cell lung carcinoma cells.

  2007cited by this paper
• The deubiquitinating enzyme USP11 controls an IkappaB kinase alpha (IKKalpha)-p53 signaling pathway in response to tumor necrosis factor alpha (TNFalpha).

  2007cited by this paper
• Targeting of AMSH to Endosomes Is Required for Epidermal Growth Factor Receptor Degradation*

  2007cited by this paper
• The Deubiquitinating Enzyme USP11 Controls an IκB Kinase α (IKKα)-p53 Signaling Pathway in Response to Tumor Necrosis Factor α (TNFα)*

  2007cited by this paper
• The emerging shape of the ESCRT machinery

  2007cited by this paper
• Gating pore current in an inherited ion channelopathy

  2007cited by this paper
• Structure-activity relationship, kinetic mechanism, and selectivity for a new class of ubiquitin C-terminal hydrolase-L1 (UCH-L1) inhibitors.

  2007cited by this paper
• Regulation of cell cycle progression and gene expression by H2A deubiquitination

  2007cited by this paper
• Small ubiquitin-like modifying protein isopeptidase assay based on poliovirus RNA polymerase activity.

  2006cited by this paper
• A role for the deubiquitinating enzyme USP28 in control of the DNA-damage response.

  2006cited by this paper
• Prostaglandin J2 Alters Pro-survival and Pro-death Gene Expression Patterns and 26 S Proteasome Assembly in Human Neuroblastoma Cells*

  2006cited by this paper
• Regulation of monoubiquitinated PCNA by DUB autocleavage

  2006cited by this paper
• Structural Basis of Ubiquitin Recognition by the Deubiquitinating Protease USP2

  2006cited by this paper
• Ubiquitin and Ubiquitin-Like Modifications of the p 53 Family 1

  2006cited by this paper
• Identification of new compounds that trigger apoptosome-independent caspase activation and apoptosis.

  2006cited by this paper
• Modification of proteins by ubiquitin and ubiquitin-like proteins.

  2006cited by this paper
• Amino-terminal Dimerization, NRDP1-Rhodanese Interaction, and Inhibited Catalytic Domain Conformation of the Ubiquitin-specific Protease 8 (USP8)*

  2006cited by this paper
• FOXO4 transcriptional activity is regulated by monoubiquitination and USP7/HAUSP

  2006cited by this paper
• Ubiquitin and ubiquitin-like modifications of the p53 family.

  2006cited by this paper
• Ubiquitin-specific protease 14 expression in colorectal cancer is associated with liver and lymph node metastases.

  2006cited by this paper
• A genomic and functional inventory of deubiquitinating enzymes.

  2005influential reference
• Regulation of epidermal growth factor receptor down-regulation by UBPY-mediated deubiquitination at endosomes.

  2005cited by this paper
• Caspase activation and apoptosis in response to proteasome inhibitors

  2005cited by this paper
• Altering protein turnover in tumor cells: new opportunities for anti-cancer therapies.

  2005cited by this paper
• VHL protein‐interacting deubiquitinating enzyme 2 deubiquitinates and stabilizes HIF‐1α

  2005cited by this paper
• Chromosome Alignment and Segregation Regulated by Ubiquitination of Survivin

  2005cited by this paper
• A novel orally active proteasome inhibitor induces apoptosis in multiple myeloma cells with mechanisms distinct from Bortezomib.

  2005cited by this paper
• Chemotherapy and the war on cancer

  2005cited by this paper
• Rapid Turnover of c-FLIPshort Is Determined by Its Unique C-terminal Tail*

  2005influential reference
• Strategies for assaying deubiquitinating enzymes.

  2005cited by this paper
• Structure and mechanisms of the proteasome‐associated deubiquitinating enzyme USP14

  2005cited by this paper
• Promoting apoptosis as a strategy for cancer drug discovery

  2005cited by this paper
• Promoting apoptosis as a strategy for cancer drug discovery

  2005cited by this paper
• Mechanism and function of deubiquitinating enzymes.

  2004influential reference
• USP6 (Tre2) Fusion Oncogenes in Aneurysmal Bone Cyst

  2004cited by this paper
• The isopeptidase USP2a regulates the stability of fatty acid synthase in prostate cancer.

  2004cited by this paper
• De-ubiquitination and ubiquitin ligase domains of A20 downregulate NF-κB signalling

  2004cited by this paper
• The flip side of FLIP.

  2004influential reference
• Ubiquitin: structures, functions, mechanisms.

  2004cited by this paper
• Oxidative Modifications and Down-regulation of Ubiquitin Carboxyl-terminal Hydrolase L1 Associated with Idiopathic Parkinson's and Alzheimer's Diseases*

  2004cited by this paper
• A dynamic role of HAUSP in the p53-Mdm2 pathway.

  2004cited by this paper
• Tumour suppression: Disruption of HAUSP gene stabilizes p53

  2004cited by this paper
• The tumour suppressor CYLD negatively regulates NF-κB signalling by deubiquitination

  2003cited by this paper

• The Inhibitory Effects of 6-Thioguanine and 6-Mercaptopurine on the USP2a Target Fatty Acid Synthase in Human Submaxillary Carcinoma Cells

  2021cites this paper
• The role of deubiquitinating enzymes in cancer drug resistance

  2020cites this paper
• Proteotoxic Stress and Cell Death in Cancer Cells

  2020cites this paper
• DUBbing Cancer: Deubiquitylating Enzymes Involved in Epigenetics, DNA Damage and the Cell Cycle As Therapeutic Targets

  2016cites this paper
• Deubiquitinases (DUBs) and DUB inhibitors: a patent review

  2015cites this paper
• Synthesis, characterization, and optimization for in vivo delivery of a nonselective isopeptidase inhibitor as new antineoplastic agent.

  2015cites this paper
• The role of ubiquitin-binding domains in human pathophysiology

  2014cites this paper
• Vialinin A is a ubiquitin-specific peptidase inhibitor.

  2013cites this paper
• Activity-based chemical proteomics accelerates inhibitor development for deubiquitylating enzymes.

  2011cites this paper